NEW YORK (GenomeWeb News) – Genetic Technologies today said that a US federal court has denied a motion by Agilent Technologies to dismiss a lawsuit in which GTG accused Agilent of infringing its primary non-coding DNA patent.

Agilent had filed its motion for dismissal, saying US Patent No. 5,612,179 held by GTG covered natural phenomena or laws of nature and therefore could not be patented. The US District Court for the Northern District of California issued an order last week denying Agilent's request, GTG said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.